The AMH test is a blood test that helps fertility specialists estimate how many eggs remain in the ovaries and how the ovaries may respond to fertility medicines. It is commonly used when planning in vitro fertilization (IVF) or egg freezing. However, AMH levels cannot tell you whether you will become pregnant or guarantee that fertility treatment will succeed.
Why Is the AMH Test Important for Fertility Treatment?
Anti-Müllerian hormone (AMH) is produced by cells surrounding developing eggs inside small ovarian follicles. These follicles are tiny fluid-filled sacs in the ovaries. Measuring AMH provides an indirect estimate of ovarian reserve, which refers to the remaining supply of eggs.
Fertility specialists use AMH results mainly to understand how the ovaries are likely to respond when medicines stimulate several eggs to develop during one treatment cycle.
According to MedlinePlus, AMH testing can help healthcare professionals plan fertility medicine doses for IVF. Higher AMH levels generally suggest a stronger ovarian response, while lower levels may indicate that fewer eggs will develop during stimulation.
This information can help clinicians discuss realistic treatment expectations. AMH is particularly useful because the number of eggs collected can influence how an IVF or egg-freezing cycle is planned.
How Is AMH Used Before IVF?
During IVF, fertility medicines encourage the ovaries to develop multiple eggs rather than the single egg that typically matures during a natural menstrual cycle. The eggs are then collected and fertilized with sperm in a laboratory.
Before treatment begins, the fertility team may measure AMH to estimate how many eggs the ovaries are likely to produce in response to stimulation.
Planning ovarian stimulation medicines
AMH results help clinicians select an initial approach to ovarian stimulation. Someone with a relatively low ovarian reserve may respond differently from someone with a high ovarian reserve, even when both receive similar medicines.
The treatment team considers AMH alongside age, ultrasound findings, medical history, and any response to previous fertility treatment. Medication doses are not chosen from an AMH number alone.
Estimating the number of eggs retrieved
One of the strongest clinical uses of AMH is estimating the ovarian response and possible egg yield during IVF.
The American Society for Reproductive Medicine (ASRM) explains that AMH and antral follicle count are useful predictors of how many eggs may be retrieved after ovarian stimulation. However, they are much less reliable for predicting egg quality, pregnancy, or live birth.
For example, a patient with low AMH may produce fewer eggs during an IVF cycle. This does not necessarily mean that none of those eggs can develop into a healthy embryo.
Identifying a possible excessive response
Higher AMH levels may indicate that the ovaries are more sensitive to stimulation medicines. In some patients, this increases concern about an excessive ovarian response.
An excessive response can increase the risk of ovarian hyperstimulation syndrome (OHSS), a complication in which the ovaries become enlarged and fluid can shift into other parts of the body.
Fertility specialists use ovarian reserve information and monitoring during treatment to select stimulation strategies intended to reduce this risk.
What AMH Level Is Good for IVF?
There is no single AMH value that guarantees IVF success. Results need to be interpreted according to age, laboratory methods, and the patient's overall fertility assessment.
AMH is commonly reported in nanograms per milliliter (ng/mL). Some laboratories use picomoles per liter (pmol/L), so the units must be checked before comparing results.
The following ranges provide general context, rather than universal treatment cutoffs:
| AMH Level | General Interpretation | Possible Relevance to IVF |
|---|---|---|
| Below 1.0 ng/mL | Often considered low | May be associated with fewer eggs developing during stimulation. |
| 1.0–3.0 ng/mL | Commonly described as an average range | May suggest a typical ovarian reserve, depending on age and other findings. |
| Above 3.0 ng/mL | May indicate a higher ovarian reserve | May be associated with a stronger response to stimulation medicines. |
These ranges should not be used to determine whether IVF is appropriate. Laboratories may use different testing methods, and a result considered typical at one age may have a different meaning at another.
Importantly, an AMH value within the average range does not ensure that IVF will produce a pregnancy. Similarly, a low value should not automatically prevent someone from receiving fertility treatment.
How Does AMH Testing Help With Egg Freezing?
Egg freezing allows eggs to be collected and stored for possible use in the future. Before starting the process, fertility specialists assess ovarian reserve to help estimate the response to stimulation medicines.
Because egg freezing usually involves the same initial ovarian stimulation and egg retrieval steps used in IVF, AMH can provide useful information about the likely number of eggs collected in one cycle.
Estimating whether more than one cycle may be needed
A patient with lower AMH may collect fewer eggs in a single cycle. Depending on age, treatment goals, and the response to medication, the fertility specialist may discuss whether additional egg-freezing cycles could be considered.
AMH cannot calculate exactly how many mature eggs will be obtained or how many frozen eggs will eventually result in a baby.
Why age matters more than AMH for future success
Age at the time eggs are frozen is especially important because egg quality and reproductive potential change with age. AMH mainly reflects egg quantity, not the likelihood that an individual egg will produce a successful pregnancy.
The UK's Human Fertilisation and Embryology Authority (HFEA) explains the egg-freezing process and emphasizes that the number of eggs collected can vary, particularly in patients with low ovarian reserve. It also explains that frozen eggs must survive thawing and further treatment before a pregnancy can occur.
For this reason, a younger person with a lower AMH level may have a different treatment outlook from an older person with a higher AMH level. Decisions about egg freezing should consider both age and ovarian response rather than either factor in isolation.
What Do Low and High AMH Results Mean for Fertility Treatment?
Low AMH and fertility treatment
Low AMH may suggest diminished ovarian reserve. In practical terms, the ovaries may produce fewer eggs when stimulated with fertility medicines.
A fertility specialist may discuss how the result affects expected egg yield, the treatment protocol, and the likelihood of needing more than one treatment cycle.
Low AMH does not necessarily mean:
- Pregnancy is impossible.
- All remaining eggs are poor quality.
- IVF cannot be attempted.
- Menopause is about to begin.
- Donor eggs are automatically required.
The significance of a low AMH result depends on the person's age, reproductive history, and other fertility findings.
High AMH and fertility treatment
High AMH commonly suggests a larger number of developing ovarian follicles. This can be associated with a stronger response to injectable fertility medicines.
High AMH may also occur in people with polycystic ovary syndrome (PCOS). However, an elevated AMH result alone is not sufficient to diagnose PCOS.
During IVF, an unexpectedly strong response may require adjustments to the stimulation plan and careful monitoring.
Neither high nor low AMH provides a complete picture of reproductive health.
Can AMH Predict IVF Success or Pregnancy?
AMH can help predict how many eggs may be collected during IVF, but it is not a reliable standalone predictor of pregnancy or live birth.
Successful IVF involves several steps. Eggs must mature, fertilization must occur, embryos must develop, and an embryo must have the potential to establish a pregnancy.
Factors beyond AMH include age, sperm quality, embryo development, underlying fertility conditions, and laboratory and treatment factors.
As Cleveland Clinic explains, AMH provides information related to ovarian reserve but cannot independently predict fertility or whether someone will become pregnant.
This distinction is important when comparing fertility treatment options. A relatively high AMH result should not create an expectation of guaranteed success, and a low result does not eliminate the possibility of pregnancy.
What Other Tests Are Used Alongside AMH?
AMH is usually one part of a broader fertility evaluation. The additional tests chosen depend on the reason for seeking treatment and the patient's medical history.
Antral follicle count (AFC)
Antral follicle count is measured using an ultrasound scan to count small follicles visible in the ovaries. Like AMH, it helps estimate ovarian reserve and expected response to stimulation.
Follicle-stimulating hormone (FSH) and estradiol
FSH and estradiol may provide additional information about ovarian function. When these hormones are measured for ovarian reserve assessment, testing is commonly performed early in the menstrual cycle.
Other fertility assessments
Depending on the circumstances, evaluation may include assessment of ovulation, the uterus and fallopian tubes, and semen testing when relevant.
According to the American Society for Reproductive Medicine's 2026 guidance on fertility evaluation, ovarian reserve tests should supplement—not replace—clinical assessment based on age, medical history, diagnosis, and previous treatment response. The guidance also notes that AMH can be measured at any point in the menstrual cycle.
Not everyone needs every fertility test. A clinician selects investigations based on the specific clinical situation.
When Should You Have an AMH Test Before IVF or Egg Freezing?
AMH is commonly measured during the initial fertility assessment, before a stimulation plan is finalized.
The blood test can generally be performed on any day of the menstrual cycle because AMH is relatively stable compared with several other reproductive hormones.
No special preparation is usually required. A healthcare professional collects a small blood sample from a vein in the arm.
Certain hormonal medicines, including hormonal contraceptives, may affect AMH measurements. Patients should tell their fertility specialist about medications they are taking rather than stopping them without medical advice.
If an AMH test was performed previously, the clinician can decide whether it remains useful for the current treatment plan or whether another measurement is needed.
Should You Repeat AMH Testing During Fertility Treatment?
Repeated AMH testing is not routinely necessary simply to track fertility over time. AMH can change, and small differences between measurements do not always represent a meaningful change in ovarian reserve.
A fertility specialist may consider another test when earlier results are unavailable, there has been an important change in clinical circumstances, or updated information is needed for treatment planning.
Once IVF stimulation begins, ultrasound scans and sometimes hormone blood tests provide more direct information about how the ovaries are responding during that particular cycle.
Does AMH Determine Which Fertility Treatment Is Best?
AMH can inform treatment planning, but it cannot determine the best option by itself.
For IVF, it helps estimate ovarian response and supports discussion of stimulation strategies. For egg freezing, it helps estimate possible egg yield. For other treatments, its usefulness depends on the clinical situation.
When discussing treatment, useful questions include how the AMH result compares with expectations for age, what the ultrasound shows, and whether the result changes the proposed treatment plan.
Some patients may benefit from proceeding with IVF, while others may be offered different approaches based on the full fertility assessment. These decisions involve more than the AMH measurement.
Key Points to Remember Before Fertility Treatment
AMH is an important planning tool for IVF and egg freezing because it helps estimate how the ovaries may respond to stimulation and how many eggs might be collected.
Its limitations are equally important. AMH cannot directly measure egg quality, guarantee pregnancy, predict the exact timing of menopause, or provide a complete assessment of fertility.
If you are considering IVF, egg freezing, or another fertility treatment, a reproductive specialist can explain your AMH result alongside your age, ultrasound findings, medical history, and personal reproductive goals. This combined assessment is more useful than interpreting a single hormone level on its own.